Literature DB >> 20802386

Efficacy of prophylactic placement of inferior vena cava filter in patients undergoing spinal surgery.

Cagatay Ozturk1, Kursat Ganiyusufoglu, Ahmet Alanay, Mehmet Aydogan, Levent Onat, Azmi Hamzaoglu.   

Abstract

STUDY
DESIGN: Retrospective case series.
OBJECTIVE: To evaluate the safety and efficacy of prophylactic inferior vena cava filter (IVCF) to prevent pulmonary embolism (PE) in high risk patients undergoing major complex spinal surgery. SUMMARY OF BACKGROUND DATA: PE has been reported to be the major cause of death after spinal reconstructive surgery. Mechanical prophylaxis alone is often not sufficient whereas anticoagulation therapy carries a significant risk of bleeding complications. Prophylactic IVCF placement is advocated in high-risk patients.
METHODS: A total of 129 high-risk patients undergoing complex spine surgery, having prophylactic IVCF were compared to a matched cohort of age, diagnosis, and risk factors of 193 patients for whom only mechanical prophylaxis was used. Patients were observed for potential complications related to the IVCF and also for clinical signs and symptoms of PE.
RESULTS: Eight cases (4.2%) of symptomatic PE were detected in the matched cohort control group (5 cases having combined anterior + posterior surgery and 3 patients having only posterior surgery). One of them died due to massive PE (0.5%). Symptomatic PE was detected in only 2 patients (1.5%), having combined anterior + posterior surgery due to lumbar spinal stenosis in IVCF group who responded well to medical treatment (P < 0.05). No complications were associated with filter insertion.
CONCLUSION: Prophylactic IVCF is effective and safe in prevention of pulmonary embolism in patients with risk factors for PE.

Entities:  

Mesh:

Year:  2010        PMID: 20802386     DOI: 10.1097/BRS.0b013e3181e91dad

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  6 in total

Review 1.  Are too many inferior vena cava filters used? Controversial evidences in different clinical settings: a narrative review.

Authors:  Michele Dalla Vestra; Elisabetta Grolla; Luca Bonanni; Raffaele Pesavento
Journal:  Intern Emerg Med       Date:  2016-11-21       Impact factor: 3.397

2.  Fatal pulmonary embolism following spinal surgery in a patient with permanent inferior vena cava filter placement.

Authors:  Noriko Takai; Yoshihiro Takasugi; Ryuji Kajikawa; Toru Takase; Yoshio Yamamoto; Shinichi Nakao
Journal:  J Anesth       Date:  2014-01-18       Impact factor: 2.078

3.  Robotic-Assisted Inferior Vena Cava Filter Retrieval.

Authors:  Shahin Owji; Tony Lu; Thomas M Loh; Adeline Schwein; Alan B Lumsden; Jean Bismuth
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Jan-Mar

4.  Inferior vena cava filters for primary prophylaxis: when are they indicated?

Authors:  Eric Wehrenberg-Klee; S William Stavropoulos
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

Review 5.  Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Evidence-Based Guideline: A Statement for Healthcare Professionals from the Neurocritical Care Society.

Authors:  Paul Nyquist; Cynthia Bautista; Draga Jichici; Joseph Burns; Sanjeev Chhangani; Michele DeFilippis; Fernando D Goldenberg; Keri Kim; Xi Liu-DeRyke; William Mack; Kim Meyer
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

6.  American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.

Authors:  David R Anderson; Gian Paolo Morgano; Carole Bennett; Francesco Dentali; Charles W Francis; David A Garcia; Susan R Kahn; Maryam Rahman; Anita Rajasekhar; Frederick B Rogers; Maureen A Smythe; Kari A O Tikkinen; Adolph J Yates; Tejan Baldeh; Sara Balduzzi; Jan L Brożek; Itziar Etxeandia- Ikobaltzeta; Herman Johal; Ignacio Neumann; Wojtek Wiercioch; Juan José Yepes-Nuñez; Holger J Schünemann; Philipp Dahm
Journal:  Blood Adv       Date:  2019-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.